India getting mixed signals from Big Pharma
The International Business Times reports that there is talk about India possibly seeing a complaint being lodged against it at the WTO due to its ‘disregard of corporate intellectual property’. This discussion came up at the US Chamber of Commerce’s event “Innovation in India: A Risky Investment?”. According to IP-Watch, the Chamber did not do most of the talking but rather presentations were made by two think tank consultants, Shankar Singham of Babson Global and Paul Howard of Manhattan Institute. IP […]
India getting mixed signals from Big Pharma Read More »